STAB (STAB:NASDAQ) soared at $3.78, representing a gain of 21.2%.
About STAB (STAB:NASDAQ)
Cytocom Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed...
Top 10 Gainers:
- LWAC (LWAC:NASDAQ), 92.95%
- AGIL (AGIL:NASDAQ), 69.4%
- Sphere 3D Corp. (ANY:NASDAQ), 41.78%
- BTCM (BTCM:NYSE), 35.19%
- LGL Systems Acquisition Corp. (DFNS:NYSE), 26.85%
- RAAS (RAAS:NYSE), 21.84%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 21.21%
- STAB (STAB:NASDAQ), 21.15%
- SCPS (SCPS:NASDAQ), 20.76%
- VERA (VERA:NASDAQ), 20.45%